6-K

TOTAL VOTING RIGHTS

Company: Indivior Pharmaceuticals, Inc.
Filed: March 1, 2024
Period of Report: March 1, 2024
Accession Number: 0001654954-24-002458

View Document ↗ View on SEC.gov ↗